FDA NDC Directory · JSON-LD · Markdown

Lumryz

NDC 13551-003 · HUMAN PRESCRIPTION DRUG · FOR SUSPENSION, EXTENDED RELEASE

Generic namesodium oxybate
Labeler / ManufacturerAvadel CNS Pharmaceuticals, LLC
Marketing categoryNew Drug Application (innovator) · App NDA214755
Dosage form / routeFOR SUSPENSION, EXTENDED RELEASE · ORAL
Active ingredientsSODIUM OXYBATE (7.5 g/1)
Marketing started20230501
Package count2

External sources

Source: openFDA. Public-domain (CC0).